Author:
Pich A,Margaria E,Chiusa L,Candelaresi G,Canton O Dal
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Alanko, A., Heinonen, E., Scheinin, T., Tolppanen, E. M. & Vihko, R. (1985). Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer 56: 1696–1700.
2. Allegra, J. C., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Green, L., Huff, K. K., Do, H. M. & Aitken, S. C. (1979). Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 39: 1447–1454.
3. Anelli, T. F., Anelli, A., Tran, K. N., Lebwohl, D. E. & Borgen, P. I. (1994). Tamoxifen administration is associated with a high rate of treatment-limiting symtoms in male breast cancer patients. Cancer 74: 74–77.
4. Bertuzzi, A., Daidone, M. G., Di Fronzo, G. & Silvestrini, R. (1981). Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res Treat 1: 253–262.
5. Bezwoda, W. R., Hesdorffer, C., Dansey, R., de Moor, N., Derman, D. P., Browde, S. & Lange, M. (1987). Breast cancer in men. Clinical features, hormone receptor staus, and response to therapy. Cancer 60: 1337–1340.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献